Athira News

Athira Pharma Analyst Ratings

BenzingaSep 19 06:52 ET

Mizuho Securities Downgrades Athira(ATHA.US) to Hold Rating, Cuts Target Price to $0.5

Moomoo NewsSep 19 05:32 ET

Jefferies Maintains Athira(ATHA.US) With Hold Rating, Cuts Target Price to $0.5

Moomoo NewsSep 18 08:33 ET

JMP Securities Maintains Athira(ATHA.US) With Hold Rating

Moomoo NewsSep 17 14:32 ET

Athira Pharma: A Cautious Hold Amid Strategic Pivot and Clinical Progress

TipRanksSep 17 13:57 ET

Mizuho Securities Maintains Athira(ATHA.US) With Buy Rating, Announces Target Price $5

Moomoo NewsSep 4 12:32 ET

Athira Pharma Cut to Market Perform From Market Outperform by JMP Securities

Dow JonesSep 4 12:23 ET

Athira Pharma Analyst Ratings

BenzingaSep 4 10:37 ET

Stifel Maintains Athira(ATHA.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsSep 4 07:33 ET

JMP Securities Downgrades Athira(ATHA.US) to Hold Rating

Moomoo NewsSep 4 00:32 ET

BTIG Downgrades Athira(ATHA.US) to Hold Rating

Moomoo NewsSep 3 20:31 ET

BTIG Downgrades Athira Pharma (ATHA) to a Hold

TipRanksSep 3 20:17 ET

Rodman & Renshaw Initiates Athira(ATHA.US) With Buy Rating, Announces Target Price $22

Moomoo NewsAug 20 07:34 ET

Athira Pharma Analyst Ratings

BenzingaAug 19 10:37 ET

Rodman & Renshaw Initiates Athira Pharma at Buy With $22 Price Target

MT NewswiresAug 19 07:27 ET

JMP Securities Maintains Athira(ATHA.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsAug 2 01:31 ET

Buy Rating Affirmed for Athira Pharma Amid Positive LIFT-AD Trial Prospects and Expanding Pipeline

TipRanksAug 2 00:57 ET

Mizuho Securities Keeps Their Buy Rating on Athira Pharma (ATHA)

TipRanksJul 10 09:30 ET

Athira Pharma Analyst Ratings

BenzingaJun 20 11:00 ET

Buy Rating Affirmed on Athira Pharma Amid Promising Alzheimer's Drug Developments and Strategic Advancements

TipRanksMay 20 02:25 ET